Catalio Capital Management »

Abivax SA F shares owned by Catalio Capital Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Catalio Capital Management from 13F filings

Historical chart of Catalio Capital Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Catalio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Catalio Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.3M 47k 111.35
2025-12-31 $13M 99k 134.86
2025-09-30 $14M 162k 84.90

More positions owned by Catalio Capital Management

Dianthus Therapeutics (DNTH)
Bridgebio Pharma (BBIO)
Ascendis Pharma A/s Sponsored Adr (ASND)
Bristol Myers Squibb (BMY)
Syndax Pharmaceuticals (SNDX)
Gilead Sciences (GILD)
Terns Pharmaceuticals (TERN)
Definium Therapeutics Com Shs (DFTX)
Soleno Therapeutics (SLNO)
Boston Scientific Corporation (BSX)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation (INCY)
Cytokinetics Com New (CYTK)
Natera (NTRA)
Corvus Pharmaceuticals (CRVS)

View all positions for Catalio Capital Management

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Morgan Stanley
Vestal Point Capital
Susquehanna International
Caligan Partners
ADAR1 Capital Management
FMR
Citadel Advisors
Westfield Capital Management Company
Barclays
Helikon Investments
Henderson Group
Baker Bros. Advisors

View all funds holding Abivax SA F